BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what we believe to be the world's premier collection of pluripotent cell assets. The foundation of our core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. Pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. Unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products.
Member count: 51-200
Phone: +1 510-521-3390
Founded date: 1990
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 15.05.2015 | Stem cell ... | OncoCyte actually draws its di... | - | - | medcitynew... |
| 17.09.2014 | Abcodia to... | Abcodia to collaborate with On... | - | - | cambridgen... |
| 09.05.2014 | LifeMap So... | LifeMap Solutions, Inc., an Al... | funding S... | - | finsmes.co... |
| 09.05.2014 | The Xconom... | Share Share on Facebook Share ... | - | Elise Crai... | xconomy.co... |
| 28.01.2011 | Regenerati... | Promoted Covid-19’s terrible ... | - | - | medcitynew... |
| - | Stem cell ... | A deep understanding of stem c... | - | - | medcitynew... |
| - | Regenerati... | Stem cell technology developer... | - | - | medcitynew... |